{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:29:25Z","timestamp":1790742565026,"version":"4.1.0"},"reference-count":18,"publisher":"American Psychiatric Association Publishing","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2004,5,1]]},"DOI":"10.1176\/appi.ajp.161.5.836","type":"journal-article","created":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T01:14:32Z","timestamp":1083374072000},"page":"836-842","source":"Crossref","is-referenced-by-count":62,"title":["A Randomized, Placebo-Controlled Trial of Sertraline for Prophylactic Treatment of Highly Recurrent Major Depressive Disorder"],"prefix":"10.1176","volume":"161","author":[{"given":"Jean-Pierre","family":"L\u00e9pine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Caillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Bisserbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Troy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Hotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"For the PREVERS Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R1615CBBGAFJC","doi-asserted-by":"crossref","unstructured":"Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H-U, Kendler KS: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51:8\u201319","DOI":"10.1001\/archpsyc.1994.03950010008002"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Wells KB, Stewart A, Hays RD, Burnam MA, Rogers W, Daniels M, Berry S, Greenfield S, Ware J: The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA 1989; 262:914\u2013919","DOI":"10.1001\/jama.262.7.914"},{"key":"R1615CBBGFJIC","doi-asserted-by":"crossref","unstructured":"Murray CJ, Lopez AD: Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349:1436\u20131442","DOI":"10.1016\/S0140-6736(96)07495-8"},{"key":"R1615CBBDGAGD","doi-asserted-by":"crossref","unstructured":"Solomon DA, Keller MB, Leon AC, Mueller TI, Lavori PW, Shea MT, Coryell W, Warshaw M, Turvey C, Maser JD, Endicott J: Multiple recurrences of major depressive disorder. Am J Psychiatry 2000; 157:229\u2013233","DOI":"10.1176\/appi.ajp.157.2.229"},{"key":"R1615CBBBCBHD","unstructured":"Kupfer DJ: Long-term treatment of depression. J Clin Psychiatry 1991; 52:28\u201334"},{"key":"R1615CBBEIDFB","doi-asserted-by":"crossref","unstructured":"Anderson IM, Nutt DJ, Deakin JFW: Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. J Psychopharmacol 2000; 14:3\u201320","DOI":"10.1177\/026988110001400101"},{"key":"R1615CBBHADBE","unstructured":"World Health Organization Mental Health Collaborating Centers: Pharmacotherapy of depressive disorders: a consensus statement. J Affect Disord 1989; 17:197\u2013198"},{"key":"R1615CBBJGHBH","doi-asserted-by":"crossref","unstructured":"Frank E, Kupfer DJ, Perel JM, Cornes C, Jarrett DB, Mallinger AG, Thase ME, McEachran AB, Grochocinski VJ: Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990; 47:1093\u20131099","DOI":"10.1001\/archpsyc.1990.01810240013002"},{"key":"R1615CBBBJGJJ","doi-asserted-by":"crossref","unstructured":"Kocsis JH, Friedman RA, Markowitz JC, Leon AC, Miller NL, Gniwesch L, Parides M: Maintenance therapy for chronic depression: a controlled clinical trial of desipramine. Arch Gen Psychiatry 1996; 53:769\u2013776","DOI":"10.1001\/archpsyc.1996.01830090013002"},{"key":"R1615CBBGIHCF","doi-asserted-by":"crossref","unstructured":"Stewart JW, Tricamo E, McGrath PJ, Quitkin FM: Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months\u2019 remission. Am J Psychiatry 1997; 154:31\u201336","DOI":"10.1176\/ajp.154.1.31"},{"key":"R1615CBBBGBBD","unstructured":"Keller MB, Kocsis JH, Thase ME, Gelenberg AJ, Rush AJ, Koran L, Schatzberg A, Russell J, Hirschfeld R, Klein D, McCullough JP, Fawcett JA, Kornstein S, LaVange L, Harrison W (Sertraline Chronic Depression Study Group): Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA 1998; 280:1665\u20131672"},{"key":"R1615CBBGGIBJ","doi-asserted-by":"crossref","unstructured":"Doogan DP, Caillard V: Sertraline in the prevention of depression. Br J Psychiatry 1992; 160:217\u2013222","DOI":"10.1192\/bjp.160.2.217"},{"key":"R1615CBBCCFJG","doi-asserted-by":"crossref","unstructured":"Montgomery SA, Dufour H, Brion S, Gailledreau J, LaQueille X, Ferrey G, Moron P, Parant-Lucena N, Singer L, Danion JM, Beuzen JN, Pierredon MA: The prophylactic efficacy of fluoxetine in unipolar depression. Br J Psychiatry Suppl 1988; 3:69\u201376","DOI":"10.1192\/S0007125000297328"},{"key":"R1615CBBBEJBC","doi-asserted-by":"crossref","unstructured":"Montgomery SA, Dunbar G: Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression. Int Clin Psychopharmacol 1993; 8:189\u2013195","DOI":"10.1097\/00004850-199300830-00009"},{"key":"R1615CBBGGFJI","doi-asserted-by":"crossref","unstructured":"Hochstrasser B, Isaksen PM, Koponen H, Lauritzen L, Mahnert FA, Rouillon F, Wade AG, Andersen M, Pedersen SF, Swart JC, Nil R: Prophylactic effect of citalopram in unipolar recurrent depression. Br J Psychiatry 2001; 178:304\u2013310","DOI":"10.1192\/bjp.178.4.304"},{"key":"R1615CBBEEEHG","doi-asserted-by":"crossref","unstructured":"Greenhouse JB, Stangl D, Kupfer DJ, Prien RF: Methodologic issues in maintenance therapy clinical trials. Arch Gen Psychiatry 1991; 48:313\u2013318","DOI":"10.1001\/archpsyc.1991.01810280029004"},{"key":"R1615CBBFFCBF","doi-asserted-by":"crossref","unstructured":"Frank E, Prien F, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rush AJ, Weissman MM: Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991; 48:851\u2013855","DOI":"10.1001\/archpsyc.1991.01810330075011"},{"key":"R1615CBBGCIHB","doi-asserted-by":"crossref","unstructured":"Montgomery SA, \u00c5sberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134:382\u2013389","DOI":"10.1192\/bjp.134.4.382"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.161.5.836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T11:40:01Z","timestamp":1722166801000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.161.5.836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,1]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5,1]]}},"alternative-id":["10.1176\/appi.ajp.161.5.836"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.161.5.836","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5,1]]}}}